[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-study-detail:100621478":3},{"organization":4,"armGroups":7,"interventions":14,"overallOfficials":10,"centralContacts":19,"locations":25,"responsibleParty":39,"collaborators":10,"id":41,"slug":42,"hasResults":43,"nctId":44,"briefTitle":45,"officialTitle":46,"acronym":10,"eligibilityCriteria":47,"healthyVolunteers":43,"sex":48,"minAge":49,"maxAge":50,"enrollmentInfo":51,"targetDuration":10,"studyType":54,"phases":10,"briefSummary":55,"conditions":56,"keywords":58,"overallStatus":62,"whyStopped":10,"lastUpdateSubmitDate":63,"lastUpdatePostDateStruct":64,"startDateStruct":67,"completionDateStruct":69,"leadSponsor":71,"locationsCount":72},{"fullName":5,"class":6},"Sevgi Medical Center","OTHER",[8],{"label":9,"type":10,"description":11,"interventionNames":12},"Helkimo Index Study Group",null,"Individuals who meet the inclusion criteria for the Turkish validity and reliability study of the Helkimo Clinical Dysfunction Index. All participants will undergo a comprehensive clinical examination and multiple scale assessments at baseline. To assess test-retest reliability, all participants will be re-evaluated after a two-week interval.",[13],"Other: Turkish Version of Helkimo Clinical Dysfunction Index and Accompanying Scales",[15],{"type":6,"name":16,"description":17,"armGroupLabels":18,"otherNames":10},"Turkish Version of Helkimo Clinical Dysfunction Index and Accompanying Scales","The intervention includes a detailed clinical assessment and a series of questionnaires. Participants will provide demographic data, trauma, and surgical history. Clinical evaluation includes the measurement of pain and jaw movements. Subjective symptoms will be assessed using the Numerical Pain Rating Scale (NPRS), linear ruler, Fonseca Anamnestic Index (FAI), and Mandibular Function Impairment Questionnaire (MFIQ). The Turkish version of the Helkimo Index will be administered to test its validity and reliability. To evaluate test-retest reliability, the entire procedure will be repeated for a subgroup after 14 days.",[9],[20],{"name":21,"role":22,"phone":23,"phoneExt":10,"email":24},"Sultan Igrek (Istanbul Beykent University), Asst. Prof.","CONTACT","+905372100654","sultanigrek@gmail.com",[26],{"facility":27,"status":10,"city":28,"state":10,"zip":10,"country":29,"countryCode":10,"cosmosGeoPoint":30,"geoPoint":35,"contacts":36},"Umay Private Oral and Dental Health Clinic","Istanbul","Turkey (Türkiye)",{"type":31,"coordinates":32},"Point",[33,34],28.94966,41.01384,{"lat":34,"lon":33},[37],{"name":38,"role":22,"phone":23,"phoneExt":10,"email":24},"Sultan Igrek, Asst. Prof",{"type":40,"investigatorFullName":10,"investigatorTitle":10,"investigatorAffiliation":10,"oldNameTitle":10,"oldOrganization":10},"SPONSOR","100621478","turkish-version-of-helkimo-clinical-dysfunction-index-100621478",false,"NCT07371143","Turkish Version of Helkimo Clinical Dysfunction Index","Turkish Adaptation, Validity, and Reliability of the Helkimo Clinical Dysfunction Index","Inclusion Criteria:\n\n* Being between 18 and 60 years of age and having been diagnosed with TMB,\n* The person must be a volunteer to participate in the study,\n* The native language must be Turkish.\n\nExclusion Criteria:\n\n* Having a history of malignant conditions, trauma, or surgery in the cranial and cervical region,\n* Inability to cooperate,\n* Regular use of analgesic and anti-inflammatory drugs,\n* Having dentofacial anomalies,\n* Having active inflammatory arthritis,\n* Having metabolic diseases (gout, osteoporosis, Cushing's disease, and hyper\u002Fhypoparathyroidism),\n* Having connective tissue, rheumatological (systemic lupus erythematosus and scleroderma), and hematological disorders (anemia and leukemia),\n* Having a diagnosed psychiatric illness,\n* Having received physical therapy related to TMB less than 6 months ago,\n* Not being a native language of Turkish","ALL","18 Years","60 Years",{"count":52,"type":53},48,"ESTIMATED","OBSERVATIONAL","This study aimed to translate the Helkimo Clinical Dysfunction Index (HCDI) into Turkish and to test its validity and reliability as an outcome measurement method in individuals with temporomandibular dysfunction (TMD). The study included 40 patients. Participants' pain intensity and range of jaw movement were measured, followed by the administration of the HDCI, the Fonseca Anamnestic Index (FAI), and the Mandibular Function Impairment Questionnaire (MFIQ). For test-retest reliability, the same questionnaire was administered again to the same patients two weeks later, and the FAI was used to test the validity of the questionnaire.",[57],"Temporomandibular Disorder (TMD)",[59,60,61],"temporomandibular disorder","helkimo clinical dysfunction Index","Turkish Adaptation, Reliability, and Validity","NOT_YET_RECRUITING","2026-01-18",{"date":65,"type":66},"2026-01-27","ACTUAL",{"date":68,"type":53},"2026-01-25",{"date":70,"type":53},"2026-03-10",{"name":5,"class":6},1]